What is NAMS's dilution risk score?

NAMS has a latest available DilutionScore record of 14/100, categorized as low dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for NAMS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for NAMS?

DilutionWatch tracks 25 SEC filing types for NAMS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect NAMS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For NAMS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for NAMS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for NAMS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

NAMS Dilution Risk Score: 14/100 (LOW)

Score Breakdown

📋 Offering Ability

22

💰 Cash Runway

0

📊 Float Risk

25

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for NAMS.

🔔 Track NAMS — Get forecast alerts →

Market Data

Market Cap$3.94B

Shares Outstanding119.54M

Float80.70M

Cash$633.85M

Debt$23.0K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 9.1% shares (2026Q1 vs prior)

173 institutional holders · 130.89M shares

#1 Frazier Life Sciences Management, L.P. 16.94M shares

#2 Capital World Investors 11.11M shares

#3 RA CAPITAL MANAGEMENT, L.P. 9.55M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest9.96M

Days to Cover9.8

% of Float12.3%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2021-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual NAMS Dilution Snapshot

NewAmsterdam Pharma Company N.V. (NAMS) has a DilutionScore of 14/100, rated Low dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for NAMS: xbrl on 2025-12-31; xbrl on 2021-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.